Results 11 to 20 of about 528 (125)

Case Report: Extensive deep vein thrombosis and venous pseudoaneurysm following percutaneous transcatheter tricuspid valve intervention [PDF]

Frontiers in Cardiovascular Medicine
IntroductionTranscatheter tricuspid valve intervention (TTVI) has evolved as a less-invasive alternative to surgical treatment of severe tricuspid regurgitation.
Zaid Abood, M. Fuad Jan, M. Fuad Jan, Eric S. Weiss, Eric S. Weiss, Tanvir Bajwa, Tanvir Bajwa, Suhail Q. Allaqaband, Suhail Q. Allaqaband, Mark W. Mewissen, Mark W. Mewissen   +10 more
doaj   +5 more sources

“Guidelines Recommendations on the Treatment of Tricuspid Regurgitation. Where Are We and Where Do We Go With Transcatheter Valve Intervention”

Frontiers in Cardiovascular Medicine, 2018
Tricuspid regurgitation (TR) is an important clinical problem because it is frequent and carries a poor prognosis when it is left uncorrected. However, there is still a lack of awareness of tricuspid disease in the medical community.
Eric Brochet, Jean-Michel Juliard
exaly   +4 more sources

Durability of benefit after transcatheter tricuspid valve intervention: insights from actigraphy [PDF]

European Journal of Heart Failure, Volume 24, Issue 7, Page 1293-1301, July 2022., 2022
Actigraphy demonstrates durable improvement of physical activity in heart failure patients with underlying significant tricuspid regurgitation after transcatheter tricuspid valve intervention. Aims Tricuspid regurgitation (TR) is associated with high mortality, morbidity and reduced physical capacity.
Thomas J. Stocker, David J. Cohen, Suzanne V. Arnold, Saskia Sommer, Daniel Braun, Lukas Stolz, Helene Hertell, Ludwig T. Weckbach, Mirjam G. Wild, Philipp Doldi, Martin Orban, Mathias Orban, Simon Deseive, Satoshi Higuchi, Steffen Massberg, Michael Nabauer, Jörg Hausleiter   +16 more
wiley   +2 more sources

Predictive value of CT-based and AI-reconstructed 3D-TAPSE in patients undergoing transcatheter tricuspid valve repair

Frontiers in Cardiovascular Medicine
BackgroundThe tricuspid annular plane systolic excursion (TAPSE) assessed by echocardiography has failed in predicting outcomes in patients with severe tricuspid regurgitation (TR) undergoing transcatheter tricuspid valve intervention (TTVI). Considering
Johannes Kirchner, Muhammed Gerçek, Hazem Omran, Kai Peter Friedrichs, Felix Rudolph, Tobias Rossnagel, Misagh Piran, Arseniy Goncharov, Maria Ivannikova, Volker Rudolph, Tanja Katharina Rudolph   +10 more
doaj   +4 more sources

Transcatheter Tricuspid Valve Therapy: From Anatomy to Intervention [PDF]

Frontiers in Cardiovascular Medicine, 2021
Nowadays, severe symptomatic tricuspid regurgitation (TR) affects millions of persons worldwide. However, the benefit of surgical correction of isolated secondary TR remains controversial because of the increased risk of periprocedural mortality and ...
Valeria Cammalleri, Myriam Carpenito, Maria Caterina Bono, Simona Mega, Gian Paolo Ussia, Francesco Grigioni   +5 more
doaj   +2 more sources

Cognitive function in late‐stage HFpEF patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention

Catheterization and Cardiovascular Interventions, Volume 100, Issue 7, Page 1323-1330, December 1, 2022., 2022
Abstract Objectives This study evaluates the impact of transcatheter tricuspid valve interventions (TTVI) on cognitive function (CF), quality of life (QOL), and exercise capacity in late‐stage heart failure with preserved ejection fraction (HFpEF) and relevant tricuspid regurgitation (TR).
Muhammed Gerçek, Anca A. Irimie, Mustafa Gerçek, Henrik Fox, Vera Fortmeier, Tanja K. Rudolph, Volker Rudolph, Kai P. Friedrichs   +7 more
wiley   +3 more sources

Burden of Heart Failure in Patients With Tricuspid Regurgitation and Effect of Transcatheter Repair on Different Subdimensions of Quality of Life

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Right‐sided heart failure (HF) due to severe tricuspid regurgitation (TR) is associated with reduced quality of life (QoL). Here, we analyzed the impact of TR on specific QoL dimensions and the effect of transcatheter tricuspid valve ...
Thomas J. Stocker, Saskia Sommer, David J. Cohen, John A. Spertus, Lukas Stolz, Philipp M. Doldi, Ludwig T. Weckbach, Michael Nabauer, Steffen Massberg, Jörg Hausleiter   +9 more
doaj   +2 more sources

Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid Regurgitation [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Tricuspid regurgitation (TR) frequently develops in patients with long‐standing pulmonary hypertension, and both pathologies are associated with increased morbidity and mortality.
Vera Fortmeier, Mark Lachmann, Matthias Unterhuber, Lukas Stolz, Mohammad Kassar, Laurin Ochs, Muhammed Gerçek, Anne R. Schöber, Thomas J. Stocker, Hazem Omran, Maria I. Körber, Amelie Hesse, Kai Peter Friedrichs, Shinsuke Yuasa, Tanja K. Rudolph, Michael Joner, Roman Pfister, Stephan Baldus, Karl‐Ludwig Laugwitz, Fabien Praz, Stephan Windecker, Jörg Hausleiter, Philipp Lurz, Volker Rudolph   +23 more
doaj   +3 more sources

Transcatheter Tricuspid Valve Intervention: Current Perspective [PDF]

US Cardiology Review, 2021
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which generates interest in therapeutic approaches to mitigate these effects.
Trevor J Simard, Mackram F Eleid
doaj   +2 more sources

Functional Tricuspid Regurgitation in the Transcatheter Aortic Valve Replacement Population and Emerging Transcatheter Tricuspid Valve Interventions [PDF]

US Cardiology Review
Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic valve disease. However, its success has brought attention to concurrent tricuspid valve disease and the inadequacy of treatments.
Molly Silkowski, Payton Kendsersky, Nicholas Amoroso   +2 more
doaj   +2 more sources